Collaboration will leverage the convenience of telehealth visits to improve access to genetic testing, speed diagnosis, and enable knowledgeable care for rare disease patients and families in Maryland
TeleRare Health launched a partnership with a leading community health system in Maryland, with a focus on expanding patient access to genetic testing, diagnosis, and knowledgeable care for rare and genetics-based diseases.
In the United States, a disease is considered rare if it affects fewer than 200,000 Americans. According to the National Institutes of Health (NIH), there are approximately 10,000 rare diseases, impacting over 30 million Americans.
Health Technology Insights: Archerfish Precision Diagnostics Launches, Advancing Diagnostic Innovation
“Frederick Health has been a steadfast innovator in genetics for over a decade, particularly as a community health system,” said Alex Katz, MD, medical geneticist and Chief Medical Officer of TeleRare Health. “The partnership with TeleRare Health expands access for rare disease patients in the region using convenient video visits to drive better outcomes, all covered by Medicare, Medicaid and Commercial plans alike.”
TeleRare Health allows patients with rare and genomic diseases to access the genetic testing and care they need and ultimately aspires to ensure all patients benefit from the AI revolution in genomics and healthcare overall.
Health Technology Insights: Linus Health Earns Major Recognition in Medical and Scientific Journals
“We’re excited to increase our capabilities through this novel partnership with TeleRare Health,” said Patricia Rice, CRNP, MSN, Clinical Director of Precision Medicine and Genetics at Frederick Health. “Our approach enables Frederick Health to offer the same top quality medical care, cutting edge sequencing technology, and indication-based molecular diagnostics to the Frederick community that a patient would receive at any quaternary or tertiary care center.”
The collaboration between Frederick Health and TeleRare Health includes three components. First, any patient needing an evaluation to determine whether genetic testing is appropriate can be seen within the Frederick Health system, without requiring outside referral. Second, by leveraging technology, telehealth, and asynchronous care as much as possible, patients will not be subject to the lengthy waitlists that often plague genetics and other specialty clinics. Finally, genomics informed medical care will be integrated into a patient’s standard healthcare without any change to existing service lines and clinical workflows.
Health Technology Insights: Laminar Pharma Shares First PFS Data for LAM561 in Glioblastoma Treatment
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source – prnewswire
